 |
| Jon Selib |
Clayton, Dubilier & Rice has named Jon Selib, who was senior VP of global policy & public affairs at Pfizer, managing director & global external affairs leader.
He will join the private investment firm in March and take responsibility for its outreach to media, trade groups and governmental units.
Selib also will work with CD&R’s portfolio companies, which includes Huntsworth, to bolster their communications efforts.
At Pfizer, Selib handled reputation, PA and policy matters and counseled CEO Albert Bourla and other top executives during the company’s rollout of the COVID-19 vaccine.
Previously, he was partner at London’s Hakluyt & Co. commercial strategy firm, in charge of its US business.
Selib has Capitol Hill experience gained while serving as chief of staff to Sen Max Baucus, who chaired the Senate Finance Committee during the legislative battle over the Affordable Care Act.
Nate Sleeper, CD&R CEO, said his firm and portfolio companies will benefit from Selib’s deep experience and strategic counsel as they confront an ever more competitive and sophisticated landscape.
The principles of liberty, self-government and individual rights are often discussed as matters of history. Last week in Odesa, Ukraine, I was reminded they are also very much matters of the present. 
How risks and opportunities have evolved for communicators in the second Trump administration.
Too many executives view public affairs as a technical task. They think that if their policy is strong, their facts are correct, and their lawyers are ready, the outcome will naturally follow. That’s a dangerous misconception.
A majority of Americans (52 percent) say president Trump launched the invasion of Iran in part to distract voters from the Jeffrey Epstein sex scandal. Forty percent disagree, according to Drop Site/Zeteo/Data for Progress survey conducted March 6-8.
